Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial (Q46052972)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial |
scientific article |
Statements
1 reference
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial (English)
1 reference
Jean-Yves Reginster
1 reference
David M Reid
1 reference
Jean-Pierre Devogelaer
1 reference
Kenneth Saag
1 reference
Christian Roux
1 reference
Chak-Sing Lau
1 reference
Philemon Papanastasiou
1 reference
Alberto Ferreira
1 reference
Florian Hartl
1 reference
Taiwo Fashola
1 reference
Peter Mesenbrink
1 reference
Philip N Sambrook
1 reference
HORIZON investigators
1 reference
1 April 2009
1 reference
1 reference
373
1 reference
1253-1263
1 reference
9671
1 reference
Identifiers
1 reference
1 reference